MGMT and glioblastoma: Furthermore, as the changes in the classification are based on detectable mutations with prognostic significance, this leaves a few such established markers for GBM, namely O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and others in need of verification, as they were established based on cohorts now representative of mixed nosological units [4-6].